User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Janus kinases affect thrombopoietin receptor cell surface localization and stability.

  1. Drachman Jonathan G., Millett Kelly M., Kaushansky Kenneth, Thrombopoietin Signal Transduction Requires Functional JAK2, Not TYK2, 10.1074/jbc.274.19.13480
  2. Blood, 92, 4 (1998)
  3. Blood, 86, 23 (1995)
  4. Blood, 89, 2789 (1997)
  5. Blood, 88, 4304 (1996)
  6. Blood, 88, 1399 (1996)
  7. Morita Haruhiko, Tahara Tomoyuki, Matsumoto Atsushi, Kato Takashi, Miyazaki Hiroshi, Ohashi Hideya, Functional analysis of the cytoplastic domain of the human Mpl receptor for tyrosine-phosphorylation of the signaling molecules, proliferation and differentiation, 10.1016/0014-5793(96)01047-2
  8. Thrombopoietin induces activation of at least two distinct signaling pathways, 10.1016/0014-5793(95)01386-5
  9. Huang Lily Jun-shen, Constantinescu Stefan N., Lodish Harvey F., The N-Terminal Domain of Janus Kinase 2 Is Required for Golgi Processing and Cell Surface Expression of Erythropoietin Receptor, 10.1016/s1097-2765(01)00401-4
  10. Radtke Simone, Hermanns Heike M., Haan Claude, Schmitz-Van de Leur Hildegard, Gascan Hugues, Heinrich Peter C., Behrmann Iris, Novel Role of Janus Kinase 1 in the Regulation of Oncostatin M Receptor Surface Expression, 10.1074/jbc.m100822200
  11. Gauzzi M. C., Barbieri G., Richter M. F., Uze G., Ling L., Fellous M., Pellegrini S., The amino-terminal region of Tyk2 sustains the level of interferon   receptor 1, a component of the interferon  /  receptor, 10.1073/pnas.94.22.11839
  12. Richter Marc F., Duménil Guillaume, Uzé Gilles, Fellous Marc, Pellegrini Sandra, Specific Contribution of Tyk2 JH Regions to the Binding and the Expression of the Interferon α/β Receptor Component IFNAR1, 10.1074/jbc.273.38.24723
  13. de Sauvage Frederic J., Hass Philip E., Spencer Susan D., Malloy Beth E., Gurney Austin L., Spencer Steven A., Darbonne Walter C., Henzel William J., Wong Suzy C., Kuang Wun-Jing, Oles Karl J., Hultgren Bruce, Solberg Lawrence A., Goeddel David V., Eaton Dan L., Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand, 10.1038/369533a0
  14. Ragimbeau J., The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression, 10.1093/emboj/cdg038
  15. Hofmann S. R., Lam A. Q., Frank S., Zhou Y.-J., Ramos H. L., Kanno Y., Agnello D., Youle R. J., O'Shea J. J., Jak3-Independent Trafficking of the Common   Chain Receptor Subunit: Chaperone Function of Jaks Revisited, 10.1128/mcb.24.11.5039-5049.2004
  16. Behrmann Iris, Smyczek Tanja, Heinrich Peter C., Schmitz-Van de Leur Hildegard, Komyod Waraporn, Giese Bernd, Müller-Newen Gerhard, Haan Serge, Haan Claude, Janus Kinase (Jak) Subcellular Localization Revisited : THE EXCLUSIVE MEMBRANE LOCALIZATION OF ENDOGENOUS JANUS KINASE 1 BY CYTOKINE RECEPTOR INTERACTION UNCOVERS THE Jak·RECEPTOR COMPLEX TO BE EQUIVALENT TO A RECEPTOR TYROSINE KINASE, 10.1074/jbc.m404202200
  17. Dahlen D. D., Internalization of the thrombopoietin receptor is regulated by 2 cytoplasmic motifs, 10.1182/blood-2002-11-3468
  18. Blood, 87, 2154 (1996)
  19. Blood, 89, 2782 (1997)
  20. Blood, 89, 1896 (1997)
  21. Li Junzhi, Xia Yuping, Kuter David J., Interaction of thrombopoietin with the platelet c-mpl receptor in plasma: binding, internalization, stability and pharmacokinetics, 10.1046/j.1365-2141.1999.01571.x
  22. Moliterno Alison R., Hankins W. David, Spivak Jerry L., Impaired Expression of the Thrombopoietin Receptor by Platelets from Patients with Polycythemia Vera, 10.1056/nejm199802263380903
  23. Blood, 94, 2555 (1999)
  24. Kaushansky Kenneth, Lok Si, Holly Richard D., Broudy Virginia C., Lin Nancy, Bailey Mason C., Forstrom John W., Buddle Michele M., Oort Pieter J., Hagen Fredrick S., Roth Gerald J., Papayannopoulou Thalia, Foster Donald C., Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin, 10.1038/369568a0
  25. Blood, 93, 2859 (1999)
  26. Dumoutier L., Van Roost E., Colau D., Renauld J.-C., Human interleukin-10-related T cell-derived inducible factor: Molecular cloning and functional characterization as an hepatocyte-stimulating factor, 10.1073/pnas.170291697
  27. Liu Xuedong, Constantinescu Stefan N., Sun Yin, Bogan Jonathan S., Hirsch David, Weinberg Robert A., Lodish Harvey F., Generation of Mammalian Cells Stably Expressing Multiple Genes at Predetermined Levels, 10.1006/abio.2000.4478
  28. Palacios Ronald, Steinmetz Michael, IL3-dependent mouse clones that express B-220 surface antigen, contain ig genes in germ-line configuration, and generate B lymphocytes in vivo, 10.1016/s0092-8674(85)80053-2
  29. Kohlhuber F, Rogers N C, Watling D, Feng J, Guschin D, Briscoe J, Witthuhn B A, Kotenko S V, Pestka S, Stark G R, Ihle J N, Kerr I M, A JAK1/JAK2 chimera can sustain alpha and gamma interferon responses., 10.1128/mcb.17.2.695
  30. Pellegrini S, John J, Shearer M, Kerr I M, Stark G R, Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway., 10.1128/mcb.9.11.4605
  31. Gossen M., Bujard H., Tight control of gene expression in mammalian cells by tetracycline-responsive promoters., 10.1073/pnas.89.12.5547
  32. Pear W. S., Nolan G. P., Scott M. L., Baltimore D., Production of high-titer helper-free retroviruses by transient transfection., 10.1073/pnas.90.18.8392
  33. Constantinescu Stefan N, Huang Lily Jun-shen, Nam Hyung-song, Lodish Harvey F, The Erythropoietin Receptor Cytosolic Juxtamembrane Domain Contains an Essential, Precisely Oriented, Hydrophobic Motif, 10.1016/s1097-2765(01)00185-x
  34. Drachman Jonathan G., Griffin James D., Kaushansky Kenneth, The c-Mpl Ligand (Thrombopoietin) Stimulates Tyrosine Phosphorylation of Jak2, Shc, and c-Mpl, 10.1074/jbc.270.10.4979
  35. Seubert Nadine, Royer Yohan, Staerk Judith, Kubatzky Katharina F, Moucadel Virginie, Krishnakumar Shyam, Smith Steven O, Constantinescu Stefan N, Active and Inactive Orientations of the Transmembrane and Cytosolic Domains of the Erythropoietin Receptor Dimer, 10.1016/s1097-2765(03)00389-7
  36. Lee Do Hee, Goldberg Alfred L, Proteasome inhibitors: valuable new tools for cell biologists, 10.1016/s0962-8924(98)01346-4
  37. Wibo M., PROTEIN DEGRADATION IN CULTURED CELLS: II. The Uptake of Chloroquine by Rat Fibroblasts and the Inhibition of Cellular Protein Degradation and Cathepsin B1, 10.1083/jcb.63.2.430
  38. Acta Biol. Med. Ger., 35, 285 (1976)
  39. KIRSCHKE Heidrun, LANGER Jurgen, WIEDERANDERS Bernd, ANSORGE Siegfried, BOHLEY Peter, Cathepsin L. A New Proteinase from Rat-Liver Lysosomes, 10.1111/j.1432-1033.1977.tb11393.x
  40. EMBO J., 14, 4905 (1995)
  41. Blood, 86, 4532 (1995)
  42. Walrafen P., Both proteasomes and lysosomes degrade the activated erythropoietin receptor, 10.1182/blood-2004-03-1216
  43. Haan Claude, Is'harc Hayaatun, Hermanns Heike M., Schmitz-Van de Leur Hildegard, Kerr Ian M., Heinrich Peter C., Grötzinger Joachim, Behrmann Iris, Mapping of a Region within the N Terminus of Jak1 Involved in Cytokine Receptor Interaction, 10.1074/jbc.m106135200
  44. Cacalano N. A., Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domain, 10.1093/emboj/18.6.1549
  45. Greiser Jens S., Stross Claudia, Heinrich Peter C., Behrmann Iris, Hermanns Heike M., Orientational Constraints of the gp130 Intracellular Juxtamembrane Domain for Signaling, 10.1074/jbc.m204113200
  46. Ezumi Yasuharu, Takayama Hiroshi, Okuma Minoru, Thrombopoietin, c-Mpl ligand, induces tyrosine phosphorylation of Tyk2, JAK2, and STAT3, and enhances agonists-induced aggregation in platelets in vitro, 10.1016/0014-5793(95)01072-m
  47. Miura O, Cleveland J L, Ihle J N, Inactivation of erythropoietin receptor function by point mutations in a region having homology with other cytokine receptors., 10.1128/mcb.13.3.1788
  48. Colamonici O, Yan H, Domanski P, Handa R, Smalley D, Mullersman J, Witte M, Krishnan K, Krolewski J, Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase., 10.1128/mcb.14.12.8133
  49. Mullersman J, A novel cytoplasmic homology domain in interferon receptors, 10.1016/s0968-0004(00)88956-2
  50. Watowich Stephanie S., Liu Kathleen D., Xie Xiaoling, Lai Stephen Y., Mikami Aki, Longmore Gregory D., Goldsmith Mark A., Oligomerization and Scaffolding Functions of the Erythropoietin Receptor Cytoplasmic Tail, 10.1074/jbc.274.9.5415
  51. Rouyez M C, Boucheron C, Gisselbrecht S, Dusanter-Fourt I, Porteu F, Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway., 10.1128/mcb.17.9.4991
  52. Shimoda Kazuya, Kato Kouji, Aoki Kenichi, Matsuda Tadashi, Miyamoto Akitomo, Shibamori Masafumi, Yamashita Masakatsu, Numata Akihiko, Takase Ken, Kobayashi Shinji, Shibata Shouichirou, Asano Yoshinobu, Gondo Hisashi, Sekiguchi Kazuo, Nakayama Keiko, Nakayama Toshinori, Okamura Takashi, Okamura Seiichi, Niho Yoshiyuki, Nakayama Kei-ichi, Tyk2 Plays a Restricted Role in IFNα Signaling, Although It Is Required for IL-12-Mediated T Cell Function, 10.1016/s1074-7613(00)00055-8
  53. HEINRICH Peter C., BEHRMANN Iris, HAAN Serge, HERMANNS Heike M., MÜLLER-NEWEN Gerhard, SCHAPER Fred, Principles of interleukin (IL)-6-type cytokine signalling and its regulation, 10.1042/bj20030407
  54. James Chloé, Ugo Valérie, Le Couédic Jean-Pierre, Staerk Judith, Delhommeau François, Lacout Catherine, Garçon Loïc, Raslova Hana, Berger Roland, Bennaceur-Griscelli Annelise, Villeval Jean Luc, Constantinescu Stefan N., Casadevall Nicole, Vainchenker William, A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera, 10.1038/nature03546
  55. BAXTER E, SCOTT L, CAMPBELL P, EAST C, FOUROUCLAS N, SWANTON S, VASSILIOU G, BENCH A, BOYD E, CURTIN N, Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders, 10.1016/s0140-6736(05)74230-6
  56. Levine Ross L., Wadleigh Martha, Cools Jan, Ebert Benjamin L., Wernig Gerlinde, Huntly Brian J.P., Boggon Titus J., Wlodarska Iwona, Clark Jennifer J., Moore Sandra, Adelsperger Jennifer, Koo Sumin, Lee Jeffrey C., Gabriel Stacey, Mercher Thomas, D’Andrea Alan, Fröhling Stefan, Döhner Konstanze, Marynen Peter, Vandenberghe Peter, Mesa Ruben A., Tefferi Ayalew, Griffin James D., Eck Michael J., Sellers William R., Meyerson Matthew, Golub Todd R., Lee Stephanie J., Gilliland D. Gary, Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis, 10.1016/j.ccr.2005.03.023
  57. RODRÍGUEZ-LIÑARES Belén, WATSON Steve P., Thrombopoietin potentiates activation of human platelets in association with JAK2 and TYK2 phosphorylation, 10.1042/bj3160093
  58. Kralovics Robert, Passamonti Francesco, Buser Andreas S., Teo Soon-Siong, Tiedt Ralph, Passweg Jakob R., Tichelli Andre, Cazzola Mario, Skoda Radek C., A Gain-of-Function Mutation ofJAK2in Myeloproliferative Disorders, 10.1056/nejmoa051113
  59. Exp. Hematol., 23, 1040 (1995)
  60. Drachman J. G., Kaushansky K., Dissecting the thrombopoietin receptor: Functional elements of the Mpl cytoplasmic domain, 10.1073/pnas.94.6.2350
  61. Blood, 85, 3444 (1995)
Bibliographic reference Royer, Yohan ; Staerk, Judith ; Costuleanu, Marcel ; Courtoy, Pierre J. ; Constantinescu, Stefan N.. Janus kinases affect thrombopoietin receptor cell surface localization and stability.. In: The Journal of biological chemistry, Vol. 280, no. 29, p. 27251-61 (2005)
Permanent URL http://hdl.handle.net/2078.1/25896